Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne muscular dystrophy (DMD)
Pharma
With FDA decision date looming, Capricor sues partner NS Pharma
With an FDA decision date looming for its DMD treatment deramiocel, Capricor has filed a lawsuit against its U.S. commercial partner, NS Pharma.
Kevin Dunleavy
May 8, 2026 11:38am
Roche to launch another Elevidys study, eying EU approval
Apr 16, 2026 10:06am
Sarepta CEO to retire, citing 'shocking and ironic twist of fate'
Feb 26, 2026 11:30am
Another setback for Enspryng as Roche halts Duchenne development
Feb 23, 2026 3:40pm
PTC withdraws US approval filing for Duchenne drug Translarna
Feb 13, 2026 10:05am
Sarepta to test Elevidys with immunosuppressive regimen
Nov 25, 2025 2:19pm
